NEW YORK--(BUSINESS WIRE)--
Bristol-Myers
Squibb Company (NYSE: BMY) will take part in Goldman Sachs 39th
Annual Global Healthcare Conference on Wednesday, June 13, 2018, in
Rancho Palos Verdes, CA. Johanna Mercier, Head of U.S. Commercial, and
Fouad Namouni, Head of Oncology Development, will answer questions about
the company at 6:20 p.m. ET (3:20 p.m. PT).
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180611006205/en/
Source: Bristol-Myers Squibb Company